Who Paid My Doc
FebriDx
Device In vitro diagnostic
General payments
$28,890
Research payments
$370,615
Through program year 2025, $28,890 in general payments and $370,615 in research payments were reported against FebriDx (In vitro diagnostic).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $24,950 | 2 |
| 2025 | Research | $356,015 | 19 |
| 2024 | General | $3,940 | 2 |
| 2024 | Research | $14,600 | 1 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
4 general · 20 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.